Skip to content
10-Q

Quarterly Report

NewGen BioPharma Corp.

0001640334-16-001208

← back to feed
Filed
Jun 14, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Jun 14, 2016 11.9M sh
Stockholders Equity Q2 2016 · Apr 30, 2016 −$100.64K
Stockholders Equity Q2 2016 · Oct 31, 2015 −$83.31K
Total Liabilities Q2 2016 · Apr 30, 2016 $100.64K
Total Liabilities Q2 2016 · Oct 31, 2015 $83.31K
Sga Expense Q2 2016 · Apr 30, 2016 $1.1K
Sga Expense Q2 2016 · Apr 30, 2016 $2.3K
Sga Expense Q2 2016 · Apr 30, 2015 $1.4K
Sga Expense Q2 2016 · Apr 30, 2015 $2.95K
Net Income Q2 2016 · Apr 30, 2016 −$6.05K
Net Income Q2 2016 · Apr 30, 2016 −$17.33K
Net Income Q2 2016 · Apr 30, 2015 −$5.39K
Net Income Q2 2016 · Apr 30, 2015 −$15.56K
Operating Income Q2 2016 · Apr 30, 2016 −$6.05K
Operating Income Q2 2016 · Apr 30, 2016 −$17.33K
Operating Income Q2 2016 · Apr 30, 2015 −$5.39K
Operating Income Q2 2016 · Apr 30, 2015 −$15.56K
Stock Issued Q2 2016 · Oct 31, 2013 2.9M sh